Week 2 (Renal) Flashcards

(147 cards)

1
Q

How does the body maintain a low, stable H+ concentration when our daily acid intake is so high?

A

1) Buffering: bicarbonate (HCO3-)
2) Excretion through kidneys
3) Elimination through lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Henderson-Hasselbach equation

A

pH = pKa + log (base/acid)

[H+] = Ka x (acid/base)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What happens when you add 1 meq H+?

A

Lose 1 meq HCO3-

Gain 1 meq CO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Normal values

A

pH: 7.37 - 7.43

[HCO3-]: 22-26 meq/L

PCO2: 38 - 42 mmHg

CO2 dis: 1.2 meq/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Extracellular and intracellular buffers

A

Extraacellular: HCO3-, inorganic phosphates, plasma proteins

Intracellular: proteins, inorganic and organic phosphates, hemoglobin, bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Renal acid excretion

A

1) Reabsorption of filtered bicarbonate: 1 meq reabsorbed HCO3- is equilvalent to 1meq decreased H+
2) Excretion of H+ by titratable acidity (combining H+ with urinary buffers like HPO4)
3) Excretion of H+ using ammonia to form ammonium (NH4+)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the anion gap?

A

Unmeasured anions (this increases in anion gap metabolic acidosis)

Weak acids (proteins like albumin)

Anion gap = Na+ - Cl- - HCO3- (or venous CO2) + [2.5 x (normal albumin - measured albumin)]

Normal anion gap is between 10 and 12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes of anion gap metabolic acidosis

A

MUDPILERS:

Methanol (formic acid), metformin

Uremia

Diabetic ketoacidosis

Propylene glycol

Iron tablets or INH or ingestions (paraldehyde)

Lactic acidosis

Ethylene glycol (oxalic acid)

Rhabdomyolysis or renal failure (sulphate, phosphate, urate, hippurate),

Salicylates (late)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lactic acidosis

A

TCA cycle requires O2 (aerobic metabolism) so when you don’t have O2, pyruvate can be reduced to lactate and NADH oxidized to NAD+ and lactate accumulates

Altered redox state: decreased oxygen delivery (shock, cardiac arrest, severe hypoxemia, CO poisoning), reduced oxygen utilization (cyanide intoxication, drug induced (zidovudine)), enhanced metabolic rate (grand mal seizure, severe exercise, severe asthma)

Increased pyruvate production: enzymatic defects in gluconeogenesis (Type I glycogen storage disease), pheochromocytoma

Impaired pyruvate utilization: decreased activity of pyruvate dehydrogenase or pyruvate carboxylase (congenital, acquired (Reye’s Syndrome))

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ketoacidosis

A

Free fatty acids: may be converted to ketoacids, acetoacetic acid, beta-hydroxybutyric acid

This occurs when: excess fatty acid delivered to liver; hepatocyte function reset preferentially converting fatty acids to ketones and not TGs

Insulin deficiency (stimulation of lipoprotein lipase with breakdown of adipose stores), glucagon excess (due in part to insulin deficiency) and increased epi secretion contribute to these changes

Etiology: uncontrolled T1DM (less commonly with T2DM), fasting (usually not severe), excessive alcohol intake

Associated problems: hypovolemia (may exacerbate acidosis), hyperosmolality causing neurologic symptoms

Treatment: insulin, volume replenishment, bicarb therapy for severe acidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Renal failure

A

Metabolic acidosis is common in advanced renal disease

Mechanism: inability to excrete daily dietary acid load (decrease total NH4+ excretion, decrease titratable acidity (phosphate), reduced HCO3- reabsorption

Usually stabilizes with a HCO3- between 12-20 meq/L and dietary protein restriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Methanol and ethylene glycol toxicity

A

Can be detected by history, serum assay, presence of significant osmolar gap (difference calculated and measured, in this case measured will be HIGHER because calculation doesn’t include methanol or ethylene glycol): Posm = 2Na + glucose/18 + BUN/28

Both metabolized to acidic agents by alcohol dehydrogenase

Treatment involves administration of ethanol (since alcohol dehydrogenase has tenfold greater binding affinity for ethanol), hemodialysis, and the treatment of the acidosis

If you see osmolar difference in setting of metabolic gap acidosis, think methanol or ethylene glycol toxicity!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Normal anion gap acidosis

A

HARD ASS:

Hyperalimentation

Addison’s disease

Renal tubular acidosis

Diarrhea

Acetazolamide

Spironolactone (or hypoaldosteronism)

Saline infusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Renal tubular acidosis Type 1 (distal)

A

Decreased H+ secretion distal renal tubules

Urine pH >5.5

Caused by: defect H+ ATPase pump, decreased cortical Na+ reabsorption, increase in membrane permeability allowing back diffusion of H+

Can be caused by autoimmune diseases (Sjogrens, lupus), drugs, obstruction

Associated with hypokalemia, increased risk for calcium phosphate stones as result of increased urine pH and bone resorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Renal tubular acidosis Type 2 (proximal)

A

Decreased proximal HCO3- reabsorption

Transient and self-limiting

Diagnosis made with trial HCO3- which causes rapid alkalinization of the urine with high fractional urine excretion of HCO3- (difficult to treat because give bicarb but is just secreted out)

Untreated patients typically have urine pH <5.5

Associated with hypokalemia, increased risk for hypophosphatemic rickets

May be seen with Fanconi’s syndrome, multiple myeloma (accumulation of proteins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Renal tubular acidosis Type 4 (hyperkalemic)

A

Hypoaldosteronism or lack of collecting tubule response to aldosterone (aldosterone normally induces H+ secretion through stimulation of H+ ATPase pump and increased luminal electronegativity through Na+ reabsorption)

Resulting hyperkalemia (because can’t excrete K+) impairs ammoniagenesis in proximal tubule, leading to decreased buffering capacity and decreased urine pH (more acidic urine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Acetazolamide

A

Carbonic anhydrase inhibitor that induces increased excretion of HCO3- and acts as a diuretic

Treatment of altitude sickness by creating metabolic acidosis inducing hyperventilation which improves high altitude adaptation

Anti-glaucoma agent: decreases aqueous humor by 50-60% (mechanism not known)

Anti-urolithic: alkalinization of urine increases uric acid and cystine solubility in the urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Treatment of acidosis

A

Treat underlying problem (lactate, ketoacids, diarrhea, etc)

IV NaHCO3 (controversial): advantages are that it improves vital organ perfusion and reduces serious dysrhythmias; disadvantages are that it causes hypernatremia, could overshoot and cause metabolic alkalosis, metabolic acidosis may be protective during ischemia, intracellular acidosis: CO2 accumulation in tissues from buffering of exogenous HCO3- or due to respiratory insufficiency

Most physicians will treat for pH <7.2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

K+ and acidosis treatment

A

Acidosis may result in normal serum K+ with significant total K+ deficit (H+ goes into cells and K+ comes out and is excreted)

This can cause a significant hypokalemia when the acidosis is treated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Metabolic alkalosis

A

Contraction alkalosis: extracellular volume contraction around constant HCO3- effectively increases HCO3- concentration: loss of fluid containing Cl- and little HCO3-, loop or thiazide diuretics, GI fluid losses, sweat losses in cystic fibrosis

Loss of H+ ion: GI loss (vomiting, antacid therapy), renal loss (loop or thiazide diuretics, mineralocorticoid excess)

Increased exogenous HCO3-: massive blood transfusion (citrate), administration of NaHCO3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Fluid losses and conditions caused

A

Vomiting: metabolic alkalosis because fluid lost contains excess H+ inrelation to HCO3-

Diarrhea: metabolic acidosis because fluid lost contains excess of HCO3-

Blood loss: no direct change because both H+ and HCO3- are lost in similar proportion to serum levels

Volume depletion: lactic acidosis caused by hypoperfusion; contraction alkalosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Respiratory acidosis

A

Rise in PCO2 (hypercapnia) is considered respiratory acidosis

Fall in PCO2 (hypocapnia) is considered respiratory alkalosis

PCO2 is controlled by only one thing: alveolar minute ventilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Control of respiration

A

Control of respiration is controlled by two sets of chemoreceptors:

Central (in medullary brainstem): primarily stimulated by increase in PCO2

Peripheral (in carotid and aortic bodies): primarily stimulated by hypoxemia and H+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Respiratory acidosis

A

Inhibition of central respiratory drive center: drugs (opiates, sedatives, anesthetics), cardiac arrest, central sleep apnea

Disorders of respiratory muscles and chest wall: myasthenia gravis, Guillain-Barre, polio, multiple sclerosis, kyphosis, obesity

Airway obstruction: aspiration, obstructive sleep apnea, laryngospasm

Disorders affecting gas exchange: ARDS, asthma, pulmonary edema, pneumothorax

Mechanical ventilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Respiratory alkalosis
**Hypoxemia**: pulmonary disease, CHF, high altitude **Direct stimulation** of respiratory center: gram-negative septicemia, hepatic failure, psychogenic, pregnancy, neurologic disorders (stroke, pontine tumors) **Mechanical ventilation**
26
Mixed acid-base disorders
Patient with **severe** **vomiting** (metabolic alkalosis) also has uncontrolled **insulin** **dependent** **diabetes** mellitus with ketoacidosis (metabolic acidosis) and may have additional **lactate** production from the **hypovolemia** causing reduced tissue perfusion (ALL CAUSE **metabolic acidosis**). Finally, there will be a **respiratory** **compensation** with hyperventilation (**respiratory** **alkalosis**)
27
Chronic renal failure (CRF) and chronic kidney disease (CKD)
A **loss** in **GFR**, often accompanied by **albuminuria** and caused by a variety of diseases, that is persistent (**\>3mo**), typically **slowly** **progressive** and **irreversible** Its manifestations, which are often **minimal in its early stages**, reflect the loss of renal homeostatic, metabolic, and endocrine and excretory functions
28
What things ultimately lead to uremia?
1) **Obstructive** uropathy, chronic **glomerulonephritis**, chronic **interstitial** **nephritis**, **diabetic nephropathy**, **hypertension**, **congenital** 2) Inexorable **loss of nephrons** and renal function 3) Homeostatic, metabolic, endocrine, excretory 4) **Uremia** Note: **elevated** **urea is NOT the cause of symptoms!** It's byproducts of protein metabolism, but uremia used as catchall phrase to describe signs and symptoms of CKD (particularly neurologic manifestations) because of ease of measurement and because historically mistakenly thought of as cause of manifestations of CKD
29
Stages of CKD
Stage 1: normal GFR (\>90 ml/min; 120 ml/min), persistent albuminuria = kidney damage with normal filtration Stage 2: GFR 60-89 ml/min, persistent albuminuria = kidney damage with mildly decreased filtration Stage 3: GFR 30-59 ml/min = moderately decreased filtration Stage 4: GFR 15-29 ml/min = severely decreased filtration Stage 5: GFR \<15 ml/min = kidney failure Note: nothing new is happening in later stages, it's just a **progression**
30
End stage renal disease (ESRD)
The stage in the evolution of CKD (**4** and **5**) when adaptive mechanisms become inadequate to avoid **morbid** and potentially **life-threatening clinical manifestations** Preparations for alternative supportive therapy (dialysis, transplantation) are required or death will ensue Note: good news that patients aren't sick at the beginning even though losing lots of GFR, but also bad news because **lose a lot of GFR without having symptoms** so don't come to get treatment until later stages
31
Common causes of CKD in the US
**Diabetes** 40% **Hypertension** 28% Clomerulonephritis 12% Polycystic disease 3% Urologic 5% Unknown 12% Note: approximately 50% of patients present with ESRD without a proven diagnosis
32
Why is kidney disease progressive?
**Reduced** **nephron** **population** or **DM --\>** glomerular **hypertension** and/or **metabolic** and **genetic** factors --\> cause glomerular injury --\> **glomerulosclerosis** --\> systemic hypertension and further decrease in total GFR --\> intraglomerular **hypertension** --\> vicious cycle Other mechanisms of how intraglomerular HTN causes glomerulosclerosis: **Endothelial damage** and **microaneurysm** formation cause **intraglomerular** **thrombosis** which causes fibrosis and liberation of plateled derived growth factors (**PDGF**) --\> **glomerulosclerosis** and **mesangial expansion** Increased mesangial traffic of macromolecules causes mesangial expansion which causes **glomerulosclerosis** Increased number of macrophages causes liberation of **growth factors** which causes increased **hyalin** formation and **mesangial** **expansion** --\> **glomerulosclerosis**
33
"Salt sandwich" of CKD
In health, we can eat as much salt as we want because can make very dilute or very concentrated urine = have high salt ceiling and low salt floor However, in **CKD**, kidney's capacity to both **retain** **salt** and **get** **rid** of it gets **worse** = ceiling gets lower and floor gets higher --\> if eat too much salt will get **hypernatremia** and/or **volume** **expansion** since ADH still working (maintain osmolality but cannot get rid of excess salt) Note: some people with CKD commit suicide by eating lots of bananas because cannot excrete K+!
34
Major signs and symptoms of uremia
**MSK**: renal **osteodystrophy**, muscle weakness, decreased growth in children, amyloid arthropathy due to beta2-microglobulin deposition **Hematologic**: anemia, platelet dysfunction **Electrolytes**: hyperkalemia, metabolic acidosis, edema, hyponatremia, hyperphosphatemia, hypocalcemia, hyperuricemia **Neurologic**: **encephalopathy**, **peripheral neuropathy** **Cardiovascular**: hypertension, pericarditis **Endocrine**: carbohydrate intolerance due to insulin resistance, hyperlipidemia, sexual dysfunction (incl infertility in women) **GI**: anorexia, nausea, vomiting
35
CKD and cardiovascular risk
Patients with any degree of CKD have a substantial increase in **cardiovascular** **risk** that can be explained in part by an increase in traditional risk factors (**HTN**, **DM**, **anemia**) as well as non-traditional risk factors (**inflammation**/vascular **calcification**) Probability of coronary artery **calcification** increases as time on dialysis increases (so need to get people transplanted) **30yo** patient on **dialysis** has same risk of **cardiovascular** **mortality** as **80yo** in general population
36
Renal osteodystrophy
**"Rugger-jersey" spine**: alternating sclerosis and porosis Absorption of distal clavicle
37
Potentially reversible causes of deterioration of CKD
**Infection** Urinary tract **obstruction** **ECF volume depletion** **CHF** **Hypertension** **Nephrotoxins** **Pericardial effusion** **Hypercalcemia** **Severe hyperuricemia**
38
Management of CKD
Treat reversible causes of renal dysfunction Prevent or slow progression (**ACEI/ARB,** diet) **Treat HTN** Limit proteinuria Prevent and treat complications Identify and prepare patients requiring **renal replacement therapy** in a timely fashion
39
Options for treatment of advanced CKD
No intervention --\> **death** from uremia **Hemodialysis** (HD): in **center** (go 4h for 3x per week) or at **home** **Peritoneal** dialysis (PD): CAPD/CCPD; need lots of training to do this so don't want to make someone go through it if will just be short term Kidney **transplantation**: living donor, deceased donor
40
CO2 dissolved vs. pCO2
**CO2** **dissolved** is dissolved in the **plasma** = **concentration** **pCO2** is is a **gas** (in the lungs?) = **partial pressure** CO2 dissolved is in **equilibrium** with pCO2 pCO2 (mmHg) x **0.03** = CO2 dissolved (concentration)
41
Other than buffering, how is it that we can add even MORE acid without changing the pH too much?
You can buffer with HCO3, but you can also **increase ventilation** (blow off CO2) In the calculation, you **don't add "x" to the numerator** or the CO2 dissolved since you'll just blow that CO2 off with increased respiration
42
After bicarb is filtered into tubular lumen, how is it reabsorbed?
**90%** is reabsorbed in **PCT** and **10%** is reabsorbed in **collecting tubule** **HCO3-** in tubular lumen combines with H+ that has been secreted --\> **H2CO3** --\> **carbonic** **anhydrase** turns that into CO2 and H2O --\> **CO2** diffuses into **PCT** (or collecting tubule) cell Inside the **PCT** cell is **negative** because of **Na/K ATPase**, and that causes **Na/3HCO3- pump** to be active in pumping those ions back into **peritubular capillary** Because of this, the CO2 that diffused into that cell is converted by **carbonic** **anhydrase** to HCO3- and is **reabsorbed** back into peritubular **capillary** Note: similar process for reabsorption in collecting tubule cell but what creates negative charge there is excretion of H+??
43
Getting rid of H+ by forming titratable acidity (using HPO4)
Most of this happens in **collecting** **tubule** (only some in PCT) Aldosterone stimulates **H+ ATPase** to secrete H+ from collecting tubule into tubular lumen --\> H+ combines with filtered **HPO4** and is excreted as H2PO4- This system is exhausted fast since only a **limited** amount of **phosphate** is **filtered**
44
Getting rid of H+ by forming urinary ammonium (NH4+)
**Ammonia** can **freely** cross into tubular lumen, and comes from most importantly **PCT** but also **collecting** **tubule cell** (intercalated Type A cell) Slightly more complex in that NH4+ partially reabsorbed in loop of henle, converted back into NH3 and then resecreted in collecting tubule lumen where is converted to NH4+ to get rid of acid **H+** from collecting tubule combines with NH3 to create ammonium (**NH4+**) and is excreted because ammonium is **trapped** and can no longer get back into cells
45
Natural history of diabetic nephropathy
1) **Increased** **GFR** 5 years after onset of T1DM, when **nephropathy** begins (may be due to increased volume due to glucose, may be due to growth factors?) --\> begin to get **microalbuminuria** as well 2) **Hyperfiltration** 3) Damage to remaining nephrons causes **fall in GFR** and damage to GBM --\> microalbuminuria turns to **heavy** **proteinuria** 4) At this point, have 20-30 years until **kidney failure** (used to be called 20 year renal retinal syndrome, but now we can treat them)
46
How does the diseased kidney maintain salt balance?
With fewer nephrons, the diseased kidney **filters** **much** **less** Na+ than usual but still excrete the same amount but **secreting a higher percent** In advanced renal failure, have very **high FENa** to stay in salt balance!
47
Pseudohyperkalemia due to thrombocytosis
Thrombocytosis with platelets \> 1,000,000 **Elevated serum** K+ but **normal plasma** K+ Due to excessive **cellular release** of K+ during **blood clotting** If put sample into tube with **no heparin**, you allow cells to **clot** which causes release of K+ (this is **serum** K+) If put sample into tube with **heparin**, **prevent clotting** and prevent release of K+ from cells (this is **plasma** K+) No therapy necessary, and in fact it is bad if you try to "treat" the patient
48
Pseudohyperkalemia due to leukocytosis
Leukocytosis with WBC \>100,000 Elevated plasma K+ but normal serum K+ Fragile white cells more susceptible to in vitro **destruction** during **centrifugation** when they are freely suspended in the plasma If put sample into tube with **no heparin**, you allow cells to **clot** so the cells **cannot** **lyse** and get **no release of K+** (this is **serum** K+) If put sample into tube with **heparin**, **prevent clotting** and cells can **lyse** and have **release of K+** from cells (this is **plasma** K+) No therapy necessary
49
Difference between pseudohyperkalemia due to thrombocytosis vs. leukocytosis
With **thrombocytosis** you get increased K+ **during clotting** so if you prevent clotting by adding heparin, you'll see actual K+ in **plasma** With **leukocytosis** you get increased K+ **during** **centrifugation** due to cell lysis so if don't add heparin, you allow clotting, just take the **serum** and get actual K+
50
Pseudohyperkalemia due to hemolysis
In vitro **hemolysis** Due to **mechanical** **trauma** during venipuncture Know its due to hemolysis because serum has **reddish** **tint** due to release of hemoglobin from red cells
51
Two ways to get true hyperkalemia
1) Extrarenal causes due to redistribution 2) Renal causes Note: very hard to get hyperkalemia by eating too much K+
52
What happens with K+ in diabetes and why?
Diabetics get **hyperkalemia** because have no insulin and **insulin** usually **stimulates Na/K pump** to pump K+ into cells
53
What inhibits Na/K pump?
**Beta blockers** **Digoxin** (Lack of insulin)
54
What happens to K+ during metabolic acidosis?
In metabolic acidosis, have too much H+ in the blood, so you bring **H+ into the cell** but must exchange that for **K+ out** K+ leaves cells and enters bloodstream so get **increased K+ in blood** (LOOKS like hyperkalemia) but **normal overall K+**
55
What happens to K+ during lactic acidosis?
In **lactic** **acidosis**, too much **H+** and **lactate-** in bloodstream **Lactate follows proton** from blood into cell to TRY TO maintain electroneutrality Still have to kick out **some** **K+**, so get a little increased K+ in the blood (but not as much as in non-lactic acid-metabolic acidosis)
56
K+ drag
When **plasma** is **hyperosmolar**, water shifts out of the cells, but **water drags K+** with it due to **friction** Remember, way more K+ inside cells than outside cells, and at this point (less water inside cells), **chemical gradient** higher than electrical gradient so K+ exits cells
57
How can tissue necrosis cause hyperkalemia?
**Tumor lysis** **Rhabdomyolysis** **In vivo hemolysis** K+ stored in cells so any process that leads to cell necrosis causes hyperkalemia
58
Can you have problems excreting K+?
Yes, **decreased urinary K+** excretion by kidneys can cause **hyperkalemia** by many mechanisms: **Hypoaldosteronism** causes hyperkalemia because **cannot excrete K+** **Aldosterone receptor blockers** **Voltage-dependent secretory defect** **Diminished ECV** **Renal failure** (GFR \<10)
59
Causes of hypoaldosteronism
**Type IV renal tubular acidosis**: hyperkalemia, low renin, low aldosterone; common in patients with diabetic nephropathy of chronic interstitial nephritis **Primary adrenal insufficiency**: hyperkalemia, decreased aldosterone production, low cortisol **Drug-induced** hypoaldosteronism: **NSAIDs** (usually stimulate renin production, but **decreased** renin causes decreased aldosterone), ACEI (inhibit ATII, inhibit aldosterone), **ARII-receptor blocker**, **heparin** (including LMW heparin toxic to adrenal gland so inhibit aldosterone), **beta** **blocker** (inhibits renin and thus aldosterone production) Note: usually aldosterone causes Na+ channels to reabsorb Na+ from lumen, leaving negative charge behind due to Cl- which causes K+ to leave the cell and be excreted
60
Aldosterone antagonists
**Spironolactone** **Eplerenone**
61
Voltage-dependent secretory defect
Remember that K+ is secreted because **Na+ reabsorption** creates **negative** charge in the lumen so **K+ wants to go out** So impairment in cortical collecting tubule Na+ reabsorption causes inability of K+ to be excreted, causing **hyperkalemia** **Type 1 RTA** (hyperkalemic form of Type 1; defect in Na+ reabsorption) Drugs: **bactrim**, pentamidine, K+ sparing diuretics which block Na+ channel (**amiloride**, **triamterene**)
62
Diminished effective circulating volume
Leads to **increased** **proximal** Na+ and water **reabsorption** This causes decreased Na+ and fluid delivery to **distal** K+ secretory site, so **less K+ excretion** since Na+ reabsorption and K+ secretion **linked** here
63
Renal failure causing hyperkalemia
If in renal failure and GFR **\<10** ml/min: **Decreased K+ filtration** Diminished Na+ and fluid delivery to distal K+ secretory site so **less K+ secretion**
64
EKG findings in hyperkalemia
**Peaking** of T waves **Flattening** of P waves **Prolongation** of PR interval **Widening** of QRS complex (to sine wave) **V-fib** or cardiac arrest Note: these things happen if K+ \>6 or 7
65
Treatment of hyperkalemia
Give **Ca2+ (calcium gluconate)** to antagonize hyperkalemic actions on cardiac membrane Drive extracellular K+ into cells: **insulin** (glucose to prevent hypoglycemia), **NaHCO3**, beta agonist (albuterol) Remove K+ from the body: diuretics (**lasix**, not ACEI or spironolactone), **kayexalate** (cation exchange resin which does Na+ exchange for K+ across the gut with no fluid loss and in fact Na+ retention causes volume expansion; use if hypovolemic), **dialysis** if severe (hemodialysis better than peritoneal for clearing K+)
66
Pseudohypokalemia due to leukocytosis
Remember, **leukocytosis** can cause pseudohyper AND pseudohypo! **Cells uptake K+ in vitro** Can prevent cellular uptake by rapid **separation** of plasma from cells or by storage of blood in **fridge** to slow metabolic activity
67
Two causes of hypokalemia
1) **Extrarenal** causes: characterized by K:creatinine ration **\<13** meq/g creatinine (kidneys **trying to conserve K+**) 2) **Renal** causes: characterized by K:creatinine ratio **\>13** meq/g creatinine (**renal K+ wasting**)
68
Extrarenal causes of hypokalemia
Decreased **K+ intake** Increased **sweat losses** **Redistribution** (cells to blood) Increased **GI losses**
69
Redistribution (K+ moving into cells) as cause of hypokalemia
**Alkalemia** (H+ out of cells and K+ in) **Insulin** (causes K+ to go into cells) Elevated **beta** **adrenergic** activity (epi, albuterol/beta-agonists cause K+ to go into cells via 3Na/2K pump) Marked increase in **blood** **cell** **production** (**folate** replacement causes cell production and those cells take up K+ to cause hypokalemia)
70
Increased Na/K exchange causing hypokalema
**Increased** distal **delivery** of **Na+** to collecting tubule will lead to **increased K+ secretion** **Diuretics** **Vomiting** **Proximal RTA** **Osmotic diuresis** (DKA) **Postobstructive diuresis** Diuretic phase of **ATN** **Mineralocorticoid excess** states
71
What do loop diuretics do?
**Block the Na/K/2Cl pump** in the thick ascending loop of henle --\> cause **hypokalemia** due to increased loss of K+ and **hypercalciuria** because can't reabsorb Ca2+ as well Mechanism of these findings: usually Na/K/2Cl pump brings those ions in from lumen and K+ is recycled back out to lumen creating **positive charge in lumen** and Cl- reabsorbed all the way to peritubular capillaries creating **negative charge in capillary** --\> this gradient causes **Ca2+, Na+ and Mg2+ to be reabsorbed** from lumen to capillary --\> but since no more gradient when you have loop diuretics that block that Na/K/2Cl pump, don't absorb as much Ca2+ and instead get hypercalciuria Loop diuretics cause **metabolic alkalosis** Loop diuretics cause **hypovolemia** which causes secondary **increased** **renin** and **increased aldosterone**
72
Thiazide diuretics
Block Na/Cl cotransporter from bringing ions in at the distal convoluted tubule --\> **hypokalemi****a**and**hypocalciuria** Can cause hypokalemia because less Na+ reabsorption..?? Drop in intracellular Na+ because less Na+ reabsorbed, and this causes Na+ to be put into cells from blood, which in turn causes **Ca2+ reabsorption** because of Ca/3Na exchanger on capillary side --\> see hypocalciuria Thiazides used in people with **kidney stones** to stimulate Ca2+ reabsorption Also get **hypovolemia**, then **increase** **renin** and **increase** **aldosterone**
73
Primary vs. secondary hyperaldosteronism
Both are mineralocorticoid excess states where you have too much aldosterone, but need to figure out etiology! Key is renin: **primary** has **decreased** **renin** and **secondary** has **increased** **renin** Both have **hypokalemia**, **metabolic** **alkalosis** (H+ secretion stimulated by aldosterone), high aldosterone **Primary** hyperaldosterism because of **adrenal adenoma, bilateral adrenal hyperplasia** (low renin in response to too much volume retention) **Secondary hyperaldosteronism** because of **renal artery stenosis** (high renin to try to "get volume up" since kidneys/afferent arterioles see low perfusion), seen in diabetics, those with arteriosclerosis
74
Treatment for hypokalemia
Can switch to **K+ sparing** diuretic (**spironolactone**, aldactone) if on thiazide or loop diuretic Can also use spironolactone/aldactone if primary hyperaldosteronism to block aldosterone action Can replace **KCl** Use **amiloride** or **triamterene** (block Na+ channel to block K+ secretion) if volume overloaded and used lasix and became hypokalemic
75
Tubulointerstitial disease
**Cystic** diseases: simple cysts, dialysis associated cysts, inherited syndomes (autosomal dominant, autosomal recessive), cystic renal dysplasia Acute tubular necrosis (**ATN**) Tubulointerstitial nephritis: **drug induced interstitial nephritis**, acute **pyelonephritis**, chronic pyelonephritis, reflux associated pyelonephritis **Obstruction** (hydronephrosis)
76
Cystic disease of the kidney
**Acquired** cysts: simple (majority), dialysis associated **Developmental**: renal dysplasia **Hereditary** cystic syndromes (ADPKD, ARPKD)
77
Simple cysts
Single or multiple Most 1-5cm (rarely 10cm) Lined by single layer of **cuboidal** **epithelium** but as cyst expands, this becomes **atrophic** and **flattened** Usually **cortical** No clinical significance other than the fact you have to distinguish them from tumors Usually **incidental** finding but rarely present with pain due to bleeding and expansion
78
Dialysis associated cysts
Patients with end stage renal disease, on prolonged dialysis Cysts in cortex and medulla, not particularly big Very rarely you can get adenomas and **carcinomas** within these cysts **Bleeding** may cause hematuria Pathogenesis: **obstruction** of tubules by **fibrosis**; is only dialysis related in that dialysis keeps patient **alive long enough** for cysts to form
79
Autosomal dominant polycystic kidney disease (ADPKD)
5-10% of renal failure Two genetic causes: **PKD1** = polycystin 1 (cell membrane protein responsible for cell-cell and cell-matrix interactions; 85%); **PKD2** = polycystin 2 (cell membrane protein that is a Ca2+ channel; 10-15%) **PKD1** develop end stage disease more **rapidly** than PKD2 High penetrance Need **mutations** in **both** alleles (either PKD1 OR PKD2, not one of each) to get cyst formation, but you **inherit one** germ line mutation and acquire a **later somatic mutation** Abnormal interaction of tubular epithelial cells with surrounding matrix (may trigger increased prolif of epithelial cells resulting in cystic dilation) Cells lining cysts have high proliferation rate and immature phenotype ECM produced by linig cells is abnormal Cysts detach from tubules and enlarge by fluid secretion (which contains mediators which enhance secretion and induce inflammation) Massive **enlargement** with time, up to 4kg, slowly expanding cysts destroy intervening parenchyma, normal renal function for decades then present with renal failure **Extrarenal** manifestations: 40% have **liver** cysts (mostly asymptomatic but occasionally cause obstruction/destruction of intrahepatic biliary tree leading to ESLD), rare cysts in **lung** and **pancreas** (inconsequential), **berry aneurysms** in circle of Willis cause death from subarachnoid hemorrhage 5-15%, **mitral valve prolapse**, sigmoid **diverticulosis** Variably sized cysts, early on parenchyma between cysts normal but then undergoes fibrosis and atrophy causing obstruction and inflammation
80
Polycistin 1-2 heterodimer in ADPKD
Polycystin 1 and 2 form **heterodimer** so malfunction of either results in same phenotype: abnormal **Ca2+** enters when heterodimer messed up --\> problems with cellular **proliferation, apoptosis, interaction with ECM, secretory function**
81
Autosomal recessive polycystic kidney disease (ARPKD)
Present in **infant/child,** is extremely **rare** PKHD1 gene with product **fibrocystin**; expressed in kidney, liver, pancreas; transmembrane protein, extracellular domain has Ig-like structure; most patients **compound heterozygotes** Serious dysfunction at birth, most have **liver** cysts also **Enlarged** kidneys with numerous cysts in cortex and medulla, dilated elongated channels virtually replace cortex and medulla On histology see **cylindrical dilation** of collecting ducts: nearly all ducts involved, all nephrons involved, renal failure **rapid**; cysts lined by cuboidal cells
82
Cystic renal dysplasia
Most common cause of abdominal mass in newborn; this is **developmental** problem, have persistence of fetal **lobar** organization; abnormal structures (**cartilage**, undifferentiated **mesenchyme**, immature **collecting** **ducts you** usually see during pregnancy only!) Variable degree of atrophy and cyst formation and not all cases are cystic Can be unilateral or bilateral Abnormal **metanephric** differentiation (**NOT premalignant**, just arranged badly) Nearly all cases associated with anomaly of **urinary** **tract** (ureteropelvic junction (UPJ) obstruction, ureteral agenesis/atresia) **Obstruction** in incompletely developed kidney results in abnormal differentiation of mesenchymal elements
83
Other cystic diseases
**Medullary sponge kidney** **Nephronophtisis** (medullary cystic disease complex)
84
Acute tubular necrosis (ATN)
Injury to **tubular epithelial cells** and/or persistent, severe disturbances in blood flow Acute diminution or loss of renal function (kidneys stop making urine, creatinine shoots up) Most **common** cause of acute renal failure, but is **reversible** Caused by **ischemia, toxic injury, obstruction** **Ischemia** causes **reduced GFR** --\> intrarenal **vasoconstriction** --\> reduced **glomerular** blood flow --\> reduced blood flow to **tubules**
85
What predisposes tubular cells to injury in ATN?
Extensive **surface area** which is highly charged for reabsorption **Transport** system for ions and organic acids Capability to carry out concentration Blood supply by **efferent** arteriole
86
Reversible structural changes induced by ischemia on tubular epithelial cells
**Loss of polarity**: redistribution of membrane proteins from basolateral surface to luminal surface This causes decreased Na+ reabsorption which causes **increased Na+ delivery** to distal tubules which through macula densa/JGA induces RAAS causing **vasoconstriction** at glomerular level which results in further decrease in blood flow to **tubules**
87
Pathogenesis of ATN
**Necrotic** epithelial cells sloughed into lumen and may **clog** tubules (decreases GFR) Loss of epithelial cells allows fluid to **leak** across basement membrane into interstitum (increased interstitial pressure further decreases blood flow) Injured epithelial cells elaborate **cytokines**
88
Factors that favor the reversibility of ATN
**Patchiness** of injury along nephron (especially with toxins that are reabsorbed by one type of PCT cell but not others) Profound dysfunction of epithelial cells (structural alterations) but **doesn't KILL** the cells High capacity to **replace** cells that were lost Note: ATN used to be fatal but now put patient on **fluids, dialysis** for short time and they go home!
89
Recovery from ATN
Proliferation of epithelial cells (cytokines and growth factors elaborated by injured epithelial cells and inflammatory cells): EGF, TGF-a, IGF, hepatocyte growth factor
90
Histology of ATN
Note: histologic severity does **NOT** **correlate** well with degree of dysfunction; different types of ATN preferentially damage diff parts of tubules and some causes of ATN have specific histo features and others don't (most don't) Ranges from mild to extensive necrosis with tubular rupture **Skip areas** (injury may be specific to certain portion of the nephron (toxins)) Attenuation/**loss of brush border** **Thinning of epithelial cells** **Vacuolization** Sloughing of necrotic cells (**necrotic** material in tubular **lumen**) **Mitotic** figures/reactive nuclear changes **Edema** Mild **mononuclear inflammation** Casts: **hyaline**, **granular** pigmented material, varying degrees of **Tamm-Horsfall proteins** (normal urinary glycoprotein) and **plasma proteins**
91
Causes of ATN associated with specific histologic features
**Mercuric chloride:** nuclear inclusions **Carbon tetrachlorid**e: accumulation of neutral lipids **Oxalosis**: primary or secondary, have numerous oxalate crystals **Light chain cast nephropathy** (**myeloma** kidney): cracked casts and giant cells
92
Oxalosis
**Primary** **oxalosis**: mutation in **gene** in **TCA cycle** that results in oxalic acid in serum which deposits in kidney and can destroy kidney; presents in infancy; get liver transplant to treat because even though **liver** looks normal, have biochemical abnormality in TCA cycle; little glomeruli and **expanded Bowman's space** since tubules **clogged** with oxalic acid and necrosis, so as glomerulus kicks out fluid, BS expands **Secondary oxalosis**: from **ethylene glycol**, rhubarb leaves
93
Types of tubulointerstitial nephritis
**Drug-induced interstitial nephritis** (most common) **Acute** infectious pyelonephritis **Chronic** pyelonephritis **Reflux associated** pyelonephritis Acute cell mediated **allograft rejection** Terms: interstitial nephritis is noninfectious; pyelonephritis is bacterial infection (but still tubulointerstitial!); both can be acute or chronic Note: glomeruli are uninvolved until late in disease
94
Interstitial nephritis
**Drugs** and **toxins** cause interstitial **immunologic** **reaction**, NOT direct toxicity Direct injury to tubules usually results in ATN, not interstitial nephritis
95
Drug induced interstitial nephritis
Caused by synthetic penicillins (**methicillin**, ampicillin), **sulfonamides, rifampin, thiazide diuretics, maybe NSAIDs** Symptoms begin **15 days** after exposure: **fever**, **eosinophilia**, **rash** (25%), **hematuria**, mild **proteinuria**, acute renal failure (particularly in elderly) Treatment: do not biopsy to diagnose, just **stop drug** right away and put patient on **steroids**
96
Histology of drug induced interstitial nephritis
Interstitial **edema** Interstitial **infiltrate**: mononuclear cells, **eosinophils** and neutrophils, **granulomas**, lymphocytic tubulitis (**lymphocytes** which cross basement membrane), tubules look farther apart than usual, have inflammatory cells and edema between them Variable degree of tubular **necrosis**, **rupture** and **repair**
97
Pathogenesis of drug induced interstitial nephritis
**Idiosyncratic** reaction (not dose related) Increased **IgE** in some patients: delayed type I hypersensitivity **Granulomas**: type IV cell mediated response Drug is reabsorbed, binds to tubular cell protein or matrix protein: acts as **hapten**
98
Nephropathy due to aristolochic acid
"Chinese" herb nephropathy, "Balkan" nephropathy Weeds producing aristolochic acid contaminate food Now used as herbal weight loss preparation Patients present in **chronic renal failure**: interstitial fibrosis with minimal inflammation Increased risk of **transitional cell carcinoma** of kidney and urinary tract
99
Acute pyelonephritis
**Suppurative** inflammatory process due to bacterial infection Most associated with **UTI** (ascending pyelonephritis) **Hematogenous** spread: seeding of kidney by organisms in blood stream
100
Ascending pyelonephritis
Only small % of UTIs result in pyelonephritis Risk from UTI associated with **repeat UTI**, **instrumentation**, anatomic anomalies, **congenital** or acquired **E. coli** most common organism, but als **Proteus**, Klebsiella, Enterobacter and Psuedomonas Colonization of lower urinary urethra is fist step: instrumentation and just being a **woman** (shorter urethra, hormonal changes affect bacterial adherence, traumatic injury from sexual intercourse, prostatic fluid antibacterial) Note: **men** have **longer urethra** and antibacterial **prostatic fluid** (more protected from UTI than women)
101
Ascending pyelonephritis from bladder up to kidneys
Multiplication of organisms in bladder: continual **flushing** and **voiding** decreases chance of bacterial growth, postvoid residual urine allows growth **Outflow obstruction**: prostatic hypertrophy, tumors, stones **Bladder dysfunction**: spinal cord injury, diabetic neuropathy **Vesicoureteral reflux**: incompetence of vesicoureteral valve allows reflux of urine into ureters; can be due to **congenital** defects (shortening of intravesicular portion of ureter so don't close it off as well), **infection** (bacterial products decrease contractility of bladder wall), **spinal cord injury** (atony of bladder) **Upper and lower poles** more often involved by pyelonephritis because **papillae** at poles have **flattened** **concave** tips (intrarenal reflux) so more susceptible to backflow of urine, papillae in mid zones pointed convex tips so are resistant to backflow (however, this just means poles affected first...eventually will get everywhere)
102
Pyelonephritis by hematogenous spread
Patients with **systemic** **bacterial** **infection** may develop pyelonephritis via **arterial** **spread** of bacteria resulting in **scattered small abscesses** throughout the kidneys Get multiple tiny abscesses everywhere when infection comes in through aorta and renal artery
103
Histology of acute pyelonephritis
**Patchy interstitial inflammation**, more prominent in medulla (ascending): neutrophils, lymphocytes, macrophages, tubular lumens filled with **neutrophils** (most specific feature), tubular necrosis, abscess formation if untreated (destruction of tissue) Note: do not do biopsy to determine if pt has pyelonephritis, this is a clinical diagnosis
104
Complications of pyelonephritis
**Papillary necrosis** (more common in diabetics, obstruction) **Pyonephritis**: pelvis filled with puss/**neutrophils** (obstruction) **Perinephric abscess**: infection and inflammation spread into perinephric fat (diabetics)
105
Chronic pyelonephritis
**Reflux** **associated**: may be clinically silent, present with renal failure or nephrotic syndrome (secondary FSGS due to subclinical nephron loss), may present with signs of acute pyelonephritis **Chronic obstruction**: extensive overlap in pathogenesis and histology Ex: child has congenital abnormality, gets veiscoureteral reflux, slowly knock off nephrons, child gets bigger so nephrons get increased load, then develop **FSGS** secondarily --\> get 13 year old presenting with **nephrotic** **syndrome** of segmentally **sclerotic** glomeruli w/background of **extensive fibrosis** Note: if there is **no scarring**, most likely **primary** FSGS
106
Obstruction
Increases susceptibility to **infection** If unrelieved, hydronephrosis develops (obstructive uropathy) Can **occur anywhere**: posterior urethral valve stricture, prostatic hypertrophy, tumors in blader, stones in ureter/bladder interface, tumors compressing/inside urethra, infections of urethra, tumors in pelvis Variability in presentation and severity and outcomes due to **sudden** vs. **insidious** onset, **partial** vs. **complete** obstruction, **unilateral** vs. **bilateral** obstruction
107
Hydronephrosis
Results in **dilation** of pelvis and calyces, atrophy or renal parenchyma **GFR reduced** but may continue after obstruction Backflow into kidney increases pressure in collecting tubules and gluid can diffuse into interstitum and then into venous and lymphatic vessels (GFR can continue) Medullary vasculature becomes compressed Decreased medullary function and **inability to concentrate** urine Triggers **inflammation** then **fibrosis** **GFR decreases** with time Get only **mild** dilation when obstruction is **sudden** and complete because **GFR impaired sooner** so don't get so much fluid buildup Get lots of **dilation** and **atrophy** when obstruction is **incomplete** or **intermittent** because **GFR less impaired**
108
Hypertension
May be **cause** or **result** of **renal disease** Complex and multifactorial pathogenesis (genetic and environmental) **95% idiopathic** (essential, primary) **5% secondary** (**renal** or **adrenal** cause)
109
Renal artery stenosis
**Rare** but **treateble** form of **secondary HTN** **Atheromatous** **plaque** at origin of renal artery **Fibromuscular dysplasia**: more common in women, have intimal/medial/adventitial forms, single constriction or a series of constrictions, clinically similar to essential HTN, angiogram for dx; this is NOT related to atherosclerosis
110
Mechanisms of secondary HTN
**Renal artery stenosis**: decreased blood flow so decreased pressure in afferent arteriole so **increased renin** and **increased Na+ reabsorption** **Pheochromocytoma**: adrenal medullary tumor releases **catecholamines** which cause **vasoconstriction**
111
Malignant HTN
Severe HTN: **\>200/120** **5%** of hypertensive patients have severe and rapid rise in BP and will **die in 2 years** if not treated Most commonly seen in patients with **preexisting benign (low grade) hypertension**
112
Factors influencing BP
**Blood volume** **Na+ content** Vascular resistance: primary **arterioles** (neural and hormonal control) **Cardiac output**
113
Renal influence on BP
**Renin/angiotensin**: increase vascular **tone**, increase distal tubular **absorption of Na+** **Antihypertensives** made by kidney: **NO, prostaglandins** Decrease in blood volume detected in kidney: decreased **GFR** results in increased Na+ reabsorption **Natiuretic** factors: made by heart, **inhibit Na+ reabsorption**
114
Essential hypertension
Few **single** **gene** examples of essential HTN Most cases represent **cumulative** effects of several genes and environment **RAAS** **Decreased** **Na+ excretion** **increased vasoconstriction** **Structural changes** to vessel walls
115
Environmental factors contributing to HTN
**Stress, obesity, smoking, physical inactivity, heavy salt consumption**
116
Pathology of HTN
HTN causes injury to **large** and **medium** sized vessles **accelerating atherogenesis** **Small** vessel disease is histologically distinct from large vessel disease: **hyaline** **arteriosclerosis** (hyalinosis = trapped plasma proteins), **hyperplastic arteriosclerosis**
117
Hyaline arteriosclerosis
Homogenous **pink**, **glassy thickening** of arterioles Loss of structural **detail** (whole wall replaced with hyaline) **Narrowing** of lumen Due to **leakage** then **accumulation** of **plasma** across endothelium **Excess** **matrix production** by smooth muscle cells in media **Arteriolar** **hyalinosis**: insudates of **plasma proteins** fill arteriolar wall resulting in decreased **luminal diameter** and decreased **contractility** Causes: **chronic** **low grade HTN**, but not just HTN: **diabetes**, **aging**, chronic calcineurin inhibitor toxicity (**cyclosporin**, FK506 = **tacrolimus**) Results in **glomerulosclerosis** through **ischemia**, glomerular **scarring** results in loss of entire nephron, small foci or scarring replace nephrons, and **contraction** of kidneys through scarring
118
Benign nephrosclerosis
Diagnostic term used to describe the changes in the kidney due to **long term benign (low grade) HTN** Increasing incidence with **age, HTN, AA, diabetics** More frequent **renal failure** in AAs, diabetics, paeitns with more severe elevation of BP **Small foci** of **scarring** from **small vessel** injury: foci of **tubular atrophy** and **interstitial** **fibrosis**, glomeruli have **wrinkled** **tufts** due to **collapsed loops,** BS filled with collagen, periglomerular fibrosis **Hyaline arteriosclerosis** Small arteries have medial hypertrophy, **duplication** of elastic lamina **Granular cortical surface** due to small foci of scarring
119
Hyperplastic arteriosclerosis
Seen in more **severe** elevations of blood pressure: **malignant** **hypertension**, **concentric** **lamination**/thickening of arterial walls, progressive **narrowing** of arterial lumens, smooth muscle cell **hypertrophy** and **hyperplasia**, thickened **reduplicated** **BM** **Fibrinoid** **necrosis** in severe examples
120
Malignant hypertension
Usually seen in patients with underlying benign HTN, **glomerulonephritis**, **scleroderma**, higher frequency in AAs and men Pathogenesis: **injury** to **arteriolar** walls, increased **permeability**, **endothelial** **injury**, endothelial **cell death**, **platelet** **aggregation**, **thrombosis**, **hyperplasia** of intimal cells (narrowing of lumens), **ischemia** (elevated renin) Small **petechial hemorrhages** on surface (due to ruptured arterioles), **fibrinoid** **necrosis** of arterioles and glomeruli (**early lesion**, eosinophilic granular material fills lumen and infiltrates wall, no or minimal inflammation) **Onion** **skinning** (**later** **lesion**) of arterioles: intimal **thickening** through **proliferation** of concentrically arranged smooth muscle cells, thin layers of **collagen** (basement membrane), layers of pale staining material (**"mucoid intimal proliferation"**) of **proteoglycans** and **plasma proteins** **Glomerular** involvement: early (**fibrin** in capillary lumens, **capillary** **microaneurysms**), later (**double** **contoured** capillary loops bc new layers of basement membrane), **ischemic** **wrinkling**, collapse of glomerular tuft (from arteriolar occlusion)
121
Thrombotic microangiopathy (TMA)
**Thrombosis** in arterioles and capillaries throughout the body, related to **hemolytic anemia, thrombocytopenia, renal failure** Malignant HTN can give picture like this, need to take hx to determine **Adult HUS**: verotoxin releasing bacteria, antiphospholipid syndrome (Lupus), pregnancy/contraceptives, drugs (chemo), radiation, scleroderma renal crisis (malignant HTN), familial HUS, idiopathic TTP, malignant HTN **Childhood HUS**: verotoxin releasing bacteria (E. coli O157:H7, which is on cheeseburgers, apple juice, spinach and bean sprouts) **Familial HUS** TMA morphology: similar to malignant HTN, **thrombi** in arterioles and glomeruli, **swollen** **endothelial** **cells**, subendothelial **fibrin**, **cell fragments**, **mesangiolysis** (disruption of BM/mesangial connection results in **capillary microaneurysms**), with time new BM material produced (see **multiple layers of BM**) by endothelial cell (if it survived) and get **double contours** ("splitting") because of damage to endothelial cells (due to HTN or bacterial toxicity in case of HUS)
122
Pathogenesis of TMA
**Endothelial** **injury**: denudation of BM exposes **thrombogenic** **collagen**, reduced production of **antithrombotic** **substances** by injured endothelial cells, triggers thrombosis **Platelet** **aggregation**: von willebrand factor **multimers** secreted by endothelial cells, are large and **must be cleaved** into smaller multimers, large multimers induce **aggregation** (if cannot break down multimers because of **loss of proteases**), congenital or acquired loss of specific proteases result in abnormally **large** **multimers** and **thrombosis**, **TTP** (many of patients deficient in ADAMTS-13, a **metalloprotease**)
123
Renal disease in diabetes
Advanced renal disease in **40%** of diabetics Clinical syndromes: **nonnephrotic proteinuria, nephrotic syndrome, chronic renal failure** HTN in diabetics increases the risk of developing **diabetic nephropathy** **Microalbuminuria**: 30-300 mg/day of albumin, develops within a few years of diabetes **Overt** **proteinuria**: \>300 mg/day develops in 50% of diabetics within 12-22 years, followed by **end stage renal disease** within **5 years** in many patients
124
Diabetic nephropathy
**Glomerular** lesions, **tubular** lesions, **vascular** lesions, **pyelonephritis** (papillary necrosis, perinephric abscesses) **Thickened** capillary loop **BM**: changes begin within few years of onset, early changes only on EM, **progressive**, simultaneous thickening of **tubular BMs** Diffuse **mesangial** **sclerosis**: mesangial expansion due to **increased** **matrix**, mild mesangial **cell** **proliferation** early in disease, with progression expansion of mesangial areas becomes **nodular**, progressive expansion **correlates** with deterioration of renal function **Nodular** **glomerular** **sclerosis**: **mesangial** **expansion** by matrix appears **nodular**, mesangiolysis often seen (disruption of sites at which capillaries are anchored to mesangium results in **capillary** **aneurysms** (distension of capillary loops due to intraglomerular pressure)), nodules expand and eventually **obliterate** **open** **loops**, **Kimmelstiel-Wilson** lesions, seen in **25%** of patients with diabetic nephropathy **Good glycemic control** slows development of diabetic nephropathy, **pancreatic transplantation** can reverse many of the changes
125
Diabetic nephropathy hyalinosis
**Hyalinosis** in glomeruli **Trapped plsama proteins** in capillary loops: **fibrin caps** (misnomer because not fibrin) **Insudates** in Bowman's capsule BM (**capsular drops**)
126
Diabetes pathogenesis
Formation of **advanced glycation end products (AGE)** Activation of **protein kinase C** **Intracellular** **hyperglycemia** with disturbances of polyol pathways **Glycosylation** of **matrix** **proteins**: abnormal matrix-matrix and matrix-cell interactions, decreased endothelial cell **adherence** to **BM** (allows increased fluid filtration (**hyalinosis**)), glycosylated proteins are more **resistant** to **proteolytic** **degradation** (decreased removal of abnormal proteins), glycosylation of BM may cause other **proteins to bind** **Circulating** **proteins** modified by **AGE residues** **Proteins** with **AGE** residues bind to AGE receptors on numerous cell types and induce production of **cytokines, growth factors, proinflammatory molecules**
127
What are the anions in the "anion gap?"
**Proteins, albumin**
128
Causes of increased anion gap
Special types of metabolic acidosis: **lactate, ketones, uremia, intoxication with salicylate, methanol, ethylene glycol, paraldehyde** (overall remember MUDPILERS) **Decreased K+, Ca2+, Mg2+** **Increased albumin** **Alkalosis** (neutral albumin shifts to albumin -)
129
Causes of decreased anion gap
**Decreased albumin** concentration (2.5 mEq/L decrease in AG for every 1g/dL decrease in albumin concentration) **Increase in K+, Ca2+, Mg2+, lithium, bromide** **Multiple myeloma** (cationic Ig: para-proteins)
130
Methanol intoxication
**Methanol** intoxication causes **metabolic gap acidosis** due to **formic acid** (which is also toxic) Causes **blindness** then **death**
131
What causes elevated plasma osmolal gap without anion gap metabolic acidosis?
**Ethanol** intoxication, **isopropyl alcohol** intoxication, **mannitol** intoxication and **glycine** administration
132
What causes anion gap metabolic acidosis with elevated plasma osmolal gap?
**Methanol** intoxication **Ethylene glycol** intoxication **Ketoacidosis** **Lactic acidosis** **Chronic renal failure**
133
What causes non-gap metabolic acidosis and elevated plasma osmolal gap?
**Multiple** **myeloma** causing **proximal renal tubular acidosis**
134
What causes elevated plasma osmolal gap and decreased plasma anion gap?
**Multiple myeloma** Patients given **IVIG** (contains maltose)
135
Salicylate (Aspirin) Toxicity
Toxic \>40-50 mg/dL **Tinnitus** --\> **vertigo** --\> **N/V** --\> **seizure** --\> **death** In early phase get **hyperventilation** (**respiratory alkalosis**) Blocking oxidative metabolism --\> **metabolic acidosis** because of accumulation of organic acids Treat with IV **bicarb** or **hemodialysis** for severe cases
136
What do dysmorphic RBCs and RBC casts indicate?
RBC casts indicate **acute glomerulonephritis** unless proven otherwise Both are indicative of glomerular process
137
Tamm-Horsfall protein
This protein is produced in thick ascending limb of loop of henle and is the **matrix** for all urinary **casts** (like **glue** that other cells that sloughed off stick to) If no cells, you can get **hyaline casts** that are just pure Tamm-Horsfall proteins
138
What happens if cells sloughed off tubules but sat for a while before exiting in the urine?
**Coarsely granular casts** mean sat around for a while (can't tell what kind of cells they are, just that they've been sitting for a while) **Finely granular casts** also sat around and **waxy casts** sat around for longest
139
How can you tell if a patient has AKI on top of CKD?
**Change in eGFR vs. time** See progressive decline in eGFR due to CKD, but if AKI then see abrupt drop too
140
Glomerular vs. tubular kidney disease
**Glomerular**: **significant** proteinuria (\>1,000 mg/day; HMW protein that gets through because of GMB damage), **dysmorphic RBCs** or **RBC casts** **Tubular**: **minimal** proteinuria (\<1,000 mg/day; this is LMW proteins that are normally filtered but now cannot be reabsorbed in PCT because tubules are damaged), **muddy brown casts** (only see this if get urine right away, might not be there the next day), **bland urine**
141
Treatment for IgA nephropathy
**Fish oil** (antiinflammatory and reduces mesangial proliferation) **Hypertension control** **ACEI or ARB** **Glucocorticoids** (if acute only?) **Alkylating cytotoxic agents** if progressive disease?
142
Slowing progression of CKD
**BP control** **RAAS inhibitors** (ACEI, ARB, if neither of those then mayb RI) Maintain serum **bicarb \>22** (chronic metabolic acidosis can interfere with bone and muscle metabolism, can induce interstitial inflammatory changes that make kidney disease progress faster; give **NaCHO3** or sodium bicitrate) Diabetics maintain **HbA1C \<7%** **Avoid NSAIDs** (especially long-acting ones like aleeve because those worse for kidney)
143
Acute vs. chronic renal failure
**Acute**: acute presentation, significant **symptoms**, **hyperkalemia**, normal to **large** kidneys, **normal hb/hct** **Chronic**: chronic history (of not feeling well for a few months), **vague** symptoms, **normo**- to hyperkalemia (gut tries to compensate and secrete K+), **small** to normal kidneys, **low hb/hct**, significant **bone disease**
144
Why don't some diabetics have small kidneys even in end stage disease?
Early in disease diabetics have **hyperfiltration** so have lots of blood in kidney and they get **enlarged** Toward **end** of disease, kidneys **sclerose** and **shrink down** but end up being about **normal sized**
145
Where is erythropoietin made?
**Peritubular cells of kidneys**
146
Urolithiasis
Kidney stones = renal calculi More common in men, age 20-30 Renal colic due to kidney stones in ureter is **horrible pain** Present with flank pain and hematuria (micro or macroscopic) Calcium stones (70%; are made of calcium oxalate), struvite stones (15%; made of Mg2+, NH4+, PO4 and usually in UTI with Proteus or Staph that convert urea to ammonia), uric acid stones (5-10%; radiolucent and associated with gout and leukemia (rapid cell turnover with uric acid production)), cystine Mostly due to idiopathic calciuria (high Ca2+ for unknown reason) but can form in those with high Ca2+ due to hyperparathyroidism, sarcoidosis, or due to bowel resection (cannot reabsorb bile acids so more bile acids excreted in gut --\> bile acids bind Ca2+ in the gut, so now oxalate cannot bind as much Ca2+ to get excreted in the gut --\> oxalate reabsorbed and filtered into urine and higher levels of oxalate being excreted in the urine and can bind Ca2+ and cause precipitation of Ca2+ stones)
147
Paraneoplastic syndromes caused by renal cell carcinoma
Polycythemia (EPO) Hypercalcemia (PTHrP) Hypertension Liver dysfunction Feminization or masculinization Cushing syndrome Leukemoid reactions Amyloidosis